the canary prostate active surveillance study (pass): cohort development, outcome modeling...
Published 3 years ago • 516 plays • Length 47:00Download video MP4
Download video MP3
Similar videos
-
17:45
point-counterpoint: oncotype dx genomic prostate score in active surveillance – canary pass study
-
50:02
active surveillance for favourable risk prostate cancer
-
45:49
prostate cancer active surveillance: rationale, outcomes and future directions
-
28:33
active surveillance results and implications of prospective studies
-
20:23
active surveillance criteria and follow-up protocol
-
38:58
active surveillance for prostate cancer
-
47:31
active surveillance in prostate cancer
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
20:50
active surveillance 2021 - from bench to bedside
-
45:27
5.27.2020 urology covid didactics - active surveillance for early stage prostate cancer
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
14:29
active surveillance at johns hopkins: update 2015
-
4:43
active surveillance - watchful waiting for prostate cancer | ucla urology - dr. leonard marks
-
16:02
dr. jim hu - active surveillance and mri targeted biopsies (prostate cancer)
-
23:37
active surveillance who is the right patient and what is the right protocol
-
7:52
prostate cancer early detection 2021
-
1:10
the urology group - active surveillance for prostate cancer
-
44:23
using biomarkers to help personalize therapy for prostate cancer patients